Actively Recruiting
Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients
Led by Centro di Riferimento Oncologico - Aviano · Updated on 2023-10-10
1098
Participants Needed
1
Research Sites
504 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The advances in early detection coupled with improvements in treatments have led to an ever increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may complement the currently available treatment options. In particular, interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, and improve survival and the quality of life.This cross-sectional, prospective, observational study aims at evaluating dietary habits and nutritional knowledge in patients with early hormone receptor positive and hormone receptor negative breast cancer.
CONDITIONS
Official Title
Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with surgically removed early stage (I-IIIa) hormone receptor-positive or hormone receptor-negative breast cancer. Hormone receptor-positive patients may be receiving endocrine therapy; hormone receptor-negative patients must be in follow-up. Targeted therapies with anti-hormonal agents allowed only in adjuvant setting
- Female patients aged 18 years or older
- Written informed consent obtained before any study assessments
You will not qualify if you...
- Patients with advanced or metastatic breast cancer
- Patients receiving (neo)adjuvant chemotherapy or anti-HER2 agents for early breast cancer
- Patients receiving active treatment for secondary primary tumors, excluding basal cell carcinoma or in situ neoplasias
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Aviano, Pordonone, Italy, 33081
Actively Recruiting
Research Team
M
Mattia Garutti, MD
CONTACT
G
Giulia Cudia, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here